LONDON: People in their 40s are likely to have to wait until May to get their Covid-19 vaccine after problems with a shipment of the AstraZeneca jab from India impacted supply.
Professor Martin Marshall, chairman of the Royal College of GPs, said news of constraints in supply was “disappointing” and “a bit of a setback”, and the focus in April in England will be on giving second doses to people who were vaccinated earlier in the year.
“The impact of this shortage of supplies will happen on the group that we were hoping to start on in April, which is the people under the age of 50 without any pre-existing conditions, who are now going to have to wait until May,” he told BBC Radio 4’s Today programme.
Cabinet minister Robert Jenrick also conceded that the rollout of vaccines would be slower than expected because of the shortage, while Professor Adam Finn, a member of the Joint Committee on Vaccination and Immunisation (JCVI), said vaccination of those aged under 50 “may kick off slightly later than we’d optimistically hoped”.
But Northern Ireland suggested it may still be able to start vaccinating people in their 40s from mid-April.
A delay in the delivery of five million doses of the AstraZeneca coronavirus vaccine from India is partly to blame for a forthcoming reduction in the UK’s supply.
The delivery had been expected from the Serum Institute of India but has been held up by four weeks.
The Housing Secretary told BBC Breakfast the final goal of vaccinating all adults with one dose by the end of July was still on track.
He said the government had learned of coronavirus vaccine supply issues “in the last few days”, and suggested the problem is not due to reductions from a single nation. “We have learned from some of our manufacturers that there are going to be some supply issues in the last few days,” he told BBC Radio 4’s Today programme. “A number of global manufacturers are experiencing issues.”
A spokesperson for the Serum Institute of India told the BBC: “Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and the requirement for the government immunisation programme in India.”
AstraZeneca has partnered with the institute, which is the world’s largest vaccine manufacturer, for supplies to the Indian government but also to other countries, including low and middle-income ones.
Meanwhile, the government has announced that shielding will formally end on April 1, with those on the shielded patient list receiving letters from Thursday.
Dr Jenny Harries, the deputy chief medical officer for England, said: “With the prevalence of the virus in the community continuing to decrease, now is the right time for people to start thinking about easing up on these more rigid guidelines.
“If you have been shielding, we strongly urge you to take extra precautions following April 1 to keep yourself as safe as possible, such as continuing to observe social distancing and working from home. We will continue to monitor all of the evidence and adjust this advice should there be any changes in infection rates.”